NCT02998983View on ClinicalTrials.gov

Racotumomab in Patients With High-risk Neuroblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Neuroblastoma
Interventions
DRUG

Racotumomab

Trial Locations (2)

1245

Prof. Dr. J. P. Garrahan National Children's Hospital, Buenos Aires

1629

Hospital Universitario Austral, Pilar

Sponsors
All Listed Sponsors
lead

Laboratorio Elea Phoenix S.A.

INDUSTRY